{"result": {"id": "451f4c77-c767-4f59-9e55-4c5b6e1386c4", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Xuezhikang and Statins in Cholesterol Management\",\n    \"summary\": \"This community focuses on the management of cholesterol levels through the use of Xuezhikang, a Chinese medicinal product, and statins, a class of drugs. The entities within this community are interconnected through their roles in cholesterol management, with Xuezhikang containing natural statin-like compounds and statins being a primary treatment for mixed dyslipidemia. The community also includes other cholesterol-lowering agents and organizations involved in creating expert consensus documents on the use of Xuezhikang.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant role these entities play in managing cholesterol levels and reducing the risk of major adverse cardiovascular events.\",\n    \"findings\": [\n        {\n            \"summary\": \"Xuezhikang's role in cholesterol management\",\n            \"explanation\": \"Xuezhikang is a Chinese medicinal product derived from red yeast rice extract, recognized for its cholesterol-lowering properties. It contains natural statin-like compounds, making it a significant entity in this community. The product's use is supported by expert consensus documents, highlighting its importance in traditional Chinese medicine for managing cholesterol levels. [Data: Entities (4421), Relationships (4262, 4500, 4501)]\"\n        },\n        {\n            \"summary\": \"Statins as a primary treatment for mixed dyslipidemia\",\n            \"explanation\": \"Statins are a primary treatment for mixed dyslipidemia, a condition characterized by elevated levels of triglycerides and cholesterol. They work by inhibiting HMG-CoA reductase to reduce cholesterol production. The effectiveness of statins in managing mixed dyslipidemia and reducing the risk of major adverse cardiovascular events underscores their importance in this community. [Data: Entities (1383, 4467), Relationships (4322, 4323, 4324)]\"\n        },\n        {\n            \"summary\": \"Combination therapies in cholesterol management\",\n            \"explanation\": \"Cholesterol absorption inhibitors and PCSK9 inhibitors are often used in combination with statins for enhanced LDL-C reduction. These combination therapies are crucial for patients who do not achieve their target LDL-C levels with statins alone, highlighting the interconnectedness of entities within this community. [Data: Entities (4422, 1374), Relationships (4263, 4319)]\"\n        },\n        {\n            \"summary\": \"Role of ω-3 fatty acids in mixed dyslipidemia treatment\",\n            \"explanation\": \"ω-3 fatty acids are used in the treatment of mixed dyslipidemia to lower triglyceride levels. They activate lipoprotein lipase to enhance triglyceride clearance and have additional benefits such as anti-inflammatory and antithrombotic effects. This makes ω-3 fatty acids a valuable component of the community's approach to managing mixed dyslipidemia. [Data: Entities (4466), Relationships (4317, 4318)]\"\n        },\n        {\n            \"summary\": \"Expert consensus on Xuezhikang use\",\n            \"explanation\": \"The Chinese expert consensus on the use of Xuezhikang, created by a working group and supported by the Committee of Cardio-Cerebro-Vascular Diseases of Gerontological Society of China, provides guidelines on the product's use. This consensus document is a key resource for understanding the therapeutic applications of Xuezhikang within the community. [Data: Entities (4654, 4655, 4653), Relationships (4500, 4501, 4499)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560422, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 743, "prompt_tokens": 3528, "total_tokens": 4271, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1536}, "prompt_cache_hit_tokens": 1536, "prompt_cache_miss_tokens": 1992}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n4421,XUEZHIKANG,\"Xuezhikang is a Chinese medicinal product derived from red yeast rice extract. It is recognized as a low-intensity cholesterol-lowering agent and has been discussed in expert consensus documents regarding its therapeutic use. The product is utilized in traditional Chinese medicine for managing cholesterol levels, combining natural extraction methods with clinically observed benefits.\",3\n1383,STATINS,,18\n4467,MIXED DYSLIPIDEMIA,\"Mixed dyslipidemia is a condition characterized by elevated levels of triglycerides and cholesterol, requiring combination therapy for management>\",3\n4422,CHOLESTEROL ABSORPTION INHIBITOR,\"**CHOLESTEROL ABSORPTION INHIBITOR** is a class of drugs that function by blocking the absorption of cholesterol in the intestine. These medications are frequently used in combination with statins, particularly when low-density lipoprotein cholesterol (LDL-C) levels remain elevated despite statin therapy. By inhibiting intestinal cholesterol absorption, they help manage cholesterol levels and improve cardiovascular outcomes. The two provided descriptions align in their explanation of the mechanism and clinical use of these drugs.\",2\n1374,PCSK9 INHIBITOR,\"**PCSK9 Inhibitor** is a class of drugs designed to lower low-density lipoprotein cholesterol (LDL-C) levels in the blood. These inhibitors work by enhancing the liver's ability to remove LDL-C, primarily through increasing the number of LDL receptors on the liver's surface. They are commonly prescribed for patients who do not achieve their target LDL-C levels with statins and ezetimibe alone. PCSK9 inhibitors are often used in combination with other lipid-lowering therapies to optimize cholesterol management. Their mechanism of action involves binding to and inhibiting the PCSK9 protein, which promotes the degradation of LDL receptors, thereby allowing more receptors to remain active and clear LDL-C from the bloodstream.\",2\n4414,ATORVASTATIN,Atorvastatin is a high-intensity statin medication used to significantly lower LDL-C levels,1\n4415,ROSUVASTATIN,Rosuvastatin is a high-intensity statin medication effective at lowering LDL-C levels,1\n4416,FLUVASTATIN,Fluvastatin is a moderate-intensity statin used for cholesterol management,1\n4417,LOVASTATIN,Lovastatin is a moderate-to-low intensity statin medication,1\n4418,PITAVASTATIN,Pitavastatin is a moderate-to-low intensity statin used for lipid control,1\n4419,PRAVASTATIN,Pravastatin is a moderate-to-low intensity statin medication,1\n4420,SIMVASTATIN,Simvastatin is a moderate-intensity statin used for cholesterol reduction,1\n4469,HMG-COA REDUCTASE,HMG-CoA reductase is the enzyme targeted by statins to inhibit cholesterol synthesis in the liver>,1\n4466,Ω-3 FATTY ACIDS,\"Prescription-grade ω-3 fatty acids are used to lower triglyceride levels by inhibiting VLDL-C generation, promoting VLDL-C clearance, and activating lipoprotein lipase activity. They also have anti-inflammatory, antithrombotic, and antioxidant effects, and can positively influence arrhythmias, endothelial function, and insulin resistance>\",3\n4654,WORKING GROUP OF CHINESE EXPERT CONSENSUS ON THE USE OF XUEZHIKANG,\"A working group responsible for the revised edition of the Chinese expert consensus on Xuezhikang\"\"\",2\n4470,LIPOPROTEIN LIPASE,Lipoprotein lipase is an enzyme activated by ω-3 fatty acids that helps break down triglycerides in the blood>,1\n4468,MACE,\"Major Adverse Cardiovascular Events (MACE) include outcomes like heart attack, stroke, or cardiovascular death, which are targeted for reduction in mixed dyslipidemia treatment>\",1\n4655,CHINESE EXPERT CONSENSUS ON THE USE OF XUEZHIKANG,\"A revised expert consensus document published in 2017\"\"\",1\n4653,COMMITTEE OF CARDIO-CEREBRO-VASCULAR DISEASES OF GERONTOLOGICAL SOCIETY OF CHINA,\"An organization involved in creating the Chinese expert consensus on the use of Xuezhikang\"\"\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n4262,XUEZHIKANG,STATINS,Xuezhikang contains natural statin-like compounds,21\n4322,STATINS,MIXED DYSLIPIDEMIA,Statins are a primary treatment for mixed dyslipidemia to lower cholesterol levels,21\n4263,CHOLESTEROL ABSORPTION INHIBITOR,STATINS,Cholesterol absorption inhibitors are often used in combination with statins for enhanced LDL-C reduction,20\n4319,PCSK9 INHIBITOR,STATINS,PCSK9 inhibitors are often combined with statins to further lower LDL cholesterol in mixed dyslipidemia,20\n4255,ATORVASTATIN,STATINS,Atorvastatin is a member of the statins drug class,19\n4256,ROSUVASTATIN,STATINS,Rosuvastatin is a member of the statins drug class,19\n4257,FLUVASTATIN,STATINS,Fluvastatin is a member of the statins drug class,19\n4258,LOVASTATIN,STATINS,Lovastatin is a member of the statins drug class,19\n4259,PITAVASTATIN,STATINS,Pitavastatin is a member of the statins drug class,19\n4260,PRAVASTATIN,STATINS,Pravastatin is a member of the statins drug class,19\n4261,SIMVASTATIN,STATINS,Simvastatin is a member of the statins drug class,19\n4323,STATINS,HMG-COA REDUCTASE,Statins work by inhibiting HMG-CoA reductase to reduce cholesterol production,19\n4317,Ω-3 FATTY ACIDS,MIXED DYSLIPIDEMIA,ω-3 fatty acids are used in the treatment of mixed dyslipidemia to lower triglyceride levels,6\n4500,WORKING GROUP OF CHINESE EXPERT CONSENSUS ON THE USE OF XUEZHIKANG,XUEZHIKANG,The working group created a consensus document on the use of Xuezhikang,5\n4318,Ω-3 FATTY ACIDS,LIPOPROTEIN LIPASE,ω-3 fatty acids activate lipoprotein lipase to enhance triglyceride clearance,4\n4324,MIXED DYSLIPIDEMIA,MACE,Effective management of mixed dyslipidemia reduces the risk of MACE,4\n4501,XUEZHIKANG,CHINESE EXPERT CONSENSUS ON THE USE OF XUEZHIKANG,The consensus document provides guidelines on the use of Xuezhikang,4\n4499,COMMITTEE OF CARDIO-CEREBRO-VASCULAR DISEASES OF GERONTOLOGICAL SOCIETY OF CHINA,WORKING GROUP OF CHINESE EXPERT CONSENSUS ON THE USE OF XUEZHIKANG,Both organizations are involved in creating the expert consensus on Xuezhikang,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_85ad13352dfbd9e2bf9f4bf3e2ac2f2d96a8ccd98972badb64b425aca098b54c_v2"}